In focus
Latest feed
The Delhi Drug Clampdown: Ensuring Safety in the Rush for Weight Loss
Innovation Over Imitation: Novo Nordisk's Bold Bet in India's Healthcare Landscape
The 'Skinny Pen' Phenomenon: A Look at India's Weight Loss Drug Revolution
The Delhi High Court's Landmark Ruling on Semaglutide: A Win for Accessibility
Latest headlines
